Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial

Abstract

Background The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that mortality at 1 year, 2 years, and 3 years is much the same with transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) for high-risk patients with aortic stenosis. We report here the 5-year outcomes.Methods We did this randomised controlled trial at 25 hospitals, in Canada (two), Germany (one), and the USA (23). We used a computer-generated randomisation sequence to randomly assign high-risk patients with severe aortic stenosis to either SAVR or TAVR with a balloon-expandable bovine pericardial tissue valve by either a transfemoral or transapical approach. Patients and their treating physicians were not masked to treatment allocation. The primary outcome of the trial was all-cause mortality in the intention-to-treat population at 1 year, we present here predefined outcomes at 5 years. The study is registered with ClinicalTrials.gov, number NCT00530894.Findings We screened 3105 patients, of whom 699 were enrolled (348 assigned to TAVR, 351 assigned to SAVR). Overall mean Society of Thoracic Surgeons Predicted Risk of Mortality score was 11·7%. At 5 years, risk of death was 67·8% in the TAVR group compared with 62·4% in the SAVR group (hazard ratio 1·04, 95% CI 0·86-1·24; p=0·76). We recorded no structural valve deterioration requiring surgical valve replacement in either group. Moderate or severe aortic regurgitation occurred in 40 (14%) of 280 patients in the TAVR group and two (1%) of 228 in the SAVR group (p<0·0001), and was associated with increased 5-year risk of mortality in the TAVR group (72·4% for moderate or severe aortic regurgitation vs 56·6% for those with mild aortic regurgitation or less; p=0·003).Interpretation Our findings show that TAVR as an alternative to surgery for patients with high surgical risk results in similar clinical outcomes.Funding Edwards Lifesciences.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(15)60308-7

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Cited by

See all 1,739

Metadata

Authors
Mack, M. J., Leon, M. B., Smith, C. R., Miller, D. C., Moses, J. W., Tuzcu, E. M., Webb, J. G., Douglas, P. S., Anderson, W. N., Blackstone, E. H., Kodali, S. K., Makkar, R. R., Fontana, G. P., Kapadia, S., Bavaria, J., Hahn, R. T., Thourani, V. H., Babaliaros, V., Pichard, A., Herrmann, H. C., Brown, D. L., Williams, M., Davidson, M. J., Svensson, L. G., & Akin, J.
Affiliations
  • Baylor Scott & White Health (US)
  • NewYork–Presbyterian Hospital (US)
  • Stanford Medicine (US)
  • Cleveland Clinic (US)
  • St. Paul's Hospital (CA)
  • Duke Medical Center (US)
  • Cedars-Sinai Medical Center (US)
  • Lenox Hill Hospital (US)
  • University of Pennsylvania (US)
  • Emory University (US)
  • MedStar Washington Hospital Center (US)
  • Heart Hospital Baylor Plano (US)
  • NYU Langone Health (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Mack, Michael J
Venue
The Lancet
Publisher
Elsevier BV
Published
2015-06
Volume
385
Issue
9986
Pages
2477-2484
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2067905792
Cited by
1,739
References
31
Citations by year
2026: 55 · 2025: 122 · 2024: 140 · 2023: 110 · 2022: 120 · 2021: 158 · 2020: 189 · 2019: 186 · 2018: 188 · 2017: 208 · 2016: 188 · 2015: 64
FWCI
157.22
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Boston Scientific Corporation
  • Medtronic
  • Abbott Vascular
  • St. Jude Medical
  • National Heart, Lung, and Blood Institute (67025)
  • Edwards Lifesciences
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Aortic Disease and Treatment Approaches
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
Keywords
transcatheter aortic valve implantation, surgical aortic valve replacement, aortic stenosis, high-risk surgical patients, five-year outcomes, all-cause mortality, aortic regurgitation, transapical approach, transfemoral access, PARTNER trial, structural valve deterioration
MeSH terms
Aged, Aged, 80 and over, Aortic Valve, Aortic Valve Insufficiency, Aortic Valve Stenosis, Canada, Cause of Death, Female, Follow-Up Studies, Germany, Humans, Male, United States, Comorbidity, Survival Rate, Survival Analysis, Treatment Outcome, Heart Valve Prosthesis Implantation, Transcatheter Aortic Valve Replacement

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(15)60308-7
The paper
Mack, M. J., Leon, M. B., Smith, C. R., Miller, D. C., Moses, J. W., Tuzcu, E. M., Webb, J. G., Douglas, P. S., Anderson, W. N., Blackstone, E. H., Kodali, S. K., Makkar, R. R., Fontana, G. P., Kapadia, S., Bavaria, J., Hahn, R. T., Thourani, V. H., Babaliaros, V., Pichard, A., . . . Akin, J. (2015). 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(15)60308-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.